Fuminori Tatsumi
Kawasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
123I-MIBG Scintigraphy-negative Pheochromocytoma without Hypertension Found During Follow-up for Non-functioning Adrenal Incidentaloma.
Journal: Internal medicine (Tokyo, Japan)
Published: October 08, 2025
Diabetic Ketoacidosis Associated with Non-occlusive Mesenteric Ischemia in a Subject with Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: August 06, 2025
A Case of Graves' Disease Exacerbation Triggered by BNT162b2 Vaccination.
Journal: Cureus
Published: May 12, 2025
A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies, a multicenter retrospective cohort study.
Journal: Journal of diabetes investigation
Published: February 12, 2025
Morphological Differences in the Abdominal Aorta Between Subjects With and Without Type 2 Diabetes.
Journal: Cureus
Published: September 03, 2024
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching.
Journal: Diabetes, obesity & metabolism
Published: May 25, 2024
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).
Journal: Frontiers in endocrinology
Published: April 05, 2024
A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors.
Journal: Medicine
Published: March 08, 2024
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis.
Journal: Endocrine journal
Published: March 06, 2024
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study).
Journal: Diabetes, obesity & metabolism
Published: June 30, 2023
Last Updated: 09/26/2026